The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...